Specifically, DPPIV is an important regulator of diabetes, obesity, hypertension, inflammation, and glucose metabolism—all of which are linked to the chronic cerebrovascular dysfunctions that follow COVID-19. This evidence concerns the gene DPP4 and COVID-19.